In MMTV-ErbB2/neu and MMTV-PyMTV models, Maroulakou et al. 26 reported that AKT1 ablation delays tumor formation, but has no effect on metastasis, whereas AKT2 ablation enhances mammary tumor growth. Here, AKT1 is linked to breast cancer.